efficacy study of a food supplement with myo-inositol, n-acetyl-cystein, zinc and vitamins on sperm dna fragmentation

Conditions: Male Infertility

Summary: in industrialised countries, it is estimated that about 15% of couples who wish to have a child are currently facing infertility problems, of which, in half of the cases, an anomaly in sperm quality or at least a factor of male origin is identified. the evaluation of sperm quality in males is based, for the most part, on the micro and macroscopic examination of various parameters (concentration, motility, physical abnormalities of the spermatozoa, etc.). nevertheless, an increasing number of scientific studies have shown that the quality of sperm dna, and in particular its fragmentation rate, is also associated with a lower fertilisation rate. the integrity of sperm dna may be affected by an imbalance in the red/ox balance leading to uncompensated oxidative stress, and could be restored or improved by dietary hygiene measures and the consumption of specific dietary products. the isitol clinical study aims to evaluate the efficacy of a dietary supplement specifically formulated to target the various issues associated with male infertility, and in particular to contribute to the improvement of the sperm dna fragmentation rate. the efficacy of the dietary supplement isitol® (gynov sas) on sperm dna fragmentation rate and other secondary parameters is being evaluated through a single-centre, prospective, randomised, double-blind, interventional vs. placebo clinical study being conducted in france at laboratoire drouot (21 rue drouot - 75009 paris - france) and led by dr. nino-guy cassuto. a total of 72 men aged between 20 and 45 years, with sperm dna fragmentation rate ≥ 30% and with negative semen culture are recruited. the recruited patients were randomized in a 1:1 scheme into 2 groups (isitol® treated vs placebo treated). \[results to be reported later\]

infertility is generally defined as a partner's failure to conceive after at least 12 months off contraception and is steadily increasing worldwide. in industrialised countries, it is estimated that around 15% of couples who wish to have a child are now facing it, and in half of the cases, an abnormality in sperm quality or at least a male factor is identified. in males, the measurement of male fertility is mainly based on analyses that assess sperm quality macroscopically (spermiogram, spermocytogram) by evaluating the number, morphology, motility, presence of abnormalities, etc. these indicators are still considered to be the preferred indicators for assessing male fertility. nevertheless, since the mid-2000s, numerous in vitro and in vivo studies in humans and animals have shown that the integrity of sperm dna, assessed by measuring the rate of dna fragmentation and chromatin decondensation in spermatozoa, could be a relevant parameter in the etiology of male infertility. furthermore, it has been observed that the rate of sperm dna fragmentation is inversely correlated with pregnancy rate, success rate of assisted reproductive techniques and embryo quality. the major identified cause of direct damage to dna molecules and their possible fragmentation, but also to proteins and cell membranes in spermatozoa is oxidative stress. unreduced reactive oxygen species produced in the mitochondria-rich midpiece in excess are susceptible to damage the dna in the sperm head. several exogenous factors such as exposure to toxins, smoking, alcohol or unbalanced diet are also associated with promoting oxidative stress. a fragmentation rate higher than 30% is considered high, it is indicative of altered chromatin and especially associated with a low probability of conceiving naturally or through in vitro techniques. to resolve this problem and improve the process of spermatogenesis and fertilisation, it is relevant to evaluate the effectiveness of a food supplement (isitol®), manufactured and marketed by the company gynov sas (2b rue sauteyron - 33000 bordeaux - france), which provides myo-inositol and a complex with antioxidant properties based on n-acetyl-cysteine, group b vitamins (b2, b3, b6, b9), vitamin e and zinc. in addition to providing the nutrients that contribute to a better management of the reactive oxygen species, the food supplement provides myo-inositol, which is essential for the functioning of a wide range of cellular functions. this molecule, related to glucose, is produced in the testis, mainly by sertoli cells, and is excreted into the seminiferous tubules as a gradient. this gradient contributes to sperm maturation by reducing sperm viscosity and increasing sperm motility. numerous studies evaluating the impact of myo-inositol have shown a significant improvement in sperm parameters (concentration, motility, morphology) and in particular in the rate of sperm dna fragmentation. in order to evaluate the efficacy of this dietary supplement, a single-centre, prospective, randomised, double-blind, interventional vs. placebo clinical study was set up in france at laboratoire drouot (21 rue drouot - 75009 paris - france) and directed by dr. nino-guy cassuto. a total of 72 men aged between 20 and 45 years, with sperm dna fragmentation rate ≥ 30% and with negative semen culture are recruited. the recruited patients were randomised in a 1:1 design into 2 groups (isitol® treated vs placebo treated). the primary hypothesis is that after 16 (± 2) weeks of treatment with the dietary supplement, the expected decrease in sperm dna fragmentation rate will be ≥ 23% compared to the placebo treated group to validate the efficacy hypothesis. the measurement of the sperm dna fragmentation rate is performed by tunel (terminal deoxynucleotidyl transferase dutp (deoxyuridine triphosphate) nick end labeling) method. the secondary objectives are the evaluation of classical sperm parameters (spermiogram, spermocytogram), sperm morphology score, chromatin decondensation rate, sperm red/ox potential, differential expression of 11 specific genes involved in spermatogenesis and/or at different stages of the fertilisation process (aurka, ccdc60, ccdc88b, etc.)). \[results to be reported later\]

Eligibility criteria:
selection criteria: * male patient volunteers aged 20 to 45 years (limits included); * socially insured patient receiving benefits from the french social security's health branch non-selection criteria: * patients suffering from infertility of infectious or genetic origin, or from a pathology requiring concomitant medical treatment; * consumption of dietary supplements during the previous 3 months and during the course of the study; * smoking ≥ 5 cigarettes/day; * alcoholism ≥ 10 drinks (alcohol standard)/week ; * body mass index (bmi) not between \[19 and 29\] (inclusive). * occupation at risk of exposure to carcinogenic, mutagenic and toxic agents for reproduction defined according to articles r.4412-2 2°, r.4412-3 and r.4412-60 of the french labour code; * patient unable to give consent; * minors and protected adults, vulnerable persons; * patient participating in another clinical research study inclusion criteria: * sperm dna fragmentation rate ≥ 30 % exclusion criteria: * positive semen culture

Keywords: spermatozoa dna fragmentation chromatin condensation food supplement tunel